140 related articles for article (PubMed ID: 9305899)
1. Identification and characterization of mutations in Ha-Ras that selectively decrease binding to cRaf-1.
Winkler DG; Johnson JC; Cooper JA; Vojtek AB
J Biol Chem; 1997 Sep; 272(39):24402-9. PubMed ID: 9305899
[TBL] [Abstract][Full Text] [Related]
2. Oncogenic Ras activation of Raf/mitogen-activated protein kinase-independent pathways is sufficient to cause tumorigenic transformation.
Khosravi-Far R; White MA; Westwick JK; Solski PA; Chrzanowska-Wodnicka M; Van Aelst L; Wigler MH; Der CJ
Mol Cell Biol; 1996 Jul; 16(7):3923-33. PubMed ID: 8668210
[TBL] [Abstract][Full Text] [Related]
3. Activation of brain B-Raf protein kinase by Rap1B small GTP-binding protein.
Ohtsuka T; Shimizu K; Yamamori B; Kuroda S; Takai Y
J Biol Chem; 1996 Jan; 271(3):1258-61. PubMed ID: 8576107
[TBL] [Abstract][Full Text] [Related]
4. Differential activation of mitogen-activated protein kinase by insulin and epidermal growth factor in 3T3-L1 adipocytes: a possible involvement of PI3-kinase in the activation of the MAP kinase by insulin.
Suga J; Yoshimasa Y; Yamada K; Yamamoto Y; Inoue G; Okamoto M; Hayashi T; Shigemoto M; Kosaki A; Kuzuya H; Nakao K
Diabetes; 1997 May; 46(5):735-41. PubMed ID: 9133538
[TBL] [Abstract][Full Text] [Related]
5. Peptides containing a consensus Ras binding sequence from Raf-1 and theGTPase activating protein NF1 inhibit Ras function.
Clark GJ; Drugan JK; Terrell RS; Bradham C; Der CJ; Bell RM; Campbell S
Proc Natl Acad Sci U S A; 1996 Feb; 93(4):1577-81. PubMed ID: 8643674
[TBL] [Abstract][Full Text] [Related]
6. The P34G mutation reduces the transforming activity of K-Ras and N-Ras in NIH 3T3 cells but not of H-Ras.
Oliva JL; Zarich N; Martínez N; Jorge R; Castrillo A; Azañedo M; García-Vargas S; Gutiérrez-Eisman S; Juarranz A; Boscá L; Gutkind JS; Rojas JM
J Biol Chem; 2004 Aug; 279(32):33480-91. PubMed ID: 15181015
[TBL] [Abstract][Full Text] [Related]
7. A role for the Ral guanine nucleotide dissociation stimulator in mediating Ras-induced transformation.
White MA; Vale T; Camonis JH; Schaefer E; Wigler MH
J Biol Chem; 1996 Jul; 271(28):16439-42. PubMed ID: 8663585
[TBL] [Abstract][Full Text] [Related]
8. Interaction of activated Ras with Raf-1 alone may be sufficient for transformation of rat2 cells.
Stang S; Bottorff D; Stone JC
Mol Cell Biol; 1997 Jun; 17(6):3047-55. PubMed ID: 9154803
[TBL] [Abstract][Full Text] [Related]
9. Akt is a direct target of the phosphatidylinositol 3-kinase. Activation by growth factors, v-src and v-Ha-ras, in Sf9 and mammalian cells.
Datta K; Bellacosa A; Chan TO; Tsichlis PN
J Biol Chem; 1996 Nov; 271(48):30835-9. PubMed ID: 8940066
[TBL] [Abstract][Full Text] [Related]
10. Ras-interacting domain of Ral GDP dissociation stimulator like (RGL) reverses v-Ras-induced transformation and Raf-1 activation in NIH3T3 cells.
Okazaki M; Kishida S; Murai H; Hinoi T; Kikuchi A
Cancer Res; 1996 May; 56(10):2387-92. PubMed ID: 8625316
[TBL] [Abstract][Full Text] [Related]
11. Rit, a non-lipid-modified Ras-related protein, transforms NIH3T3 cells without activating the ERK, JNK, p38 MAPK or PI3K/Akt pathways.
Rusyn EV; Reynolds ER; Shao H; Grana TM; Chan TO; Andres DA; Cox AD
Oncogene; 2000 Sep; 19(41):4685-94. PubMed ID: 11032018
[TBL] [Abstract][Full Text] [Related]
12. Regulation of interaction of ras p21 with RalGDS and Raf-1 by cyclic AMP-dependent protein kinase.
Kikuchi A; Williams LT
J Biol Chem; 1996 Jan; 271(1):588-94. PubMed ID: 8550624
[TBL] [Abstract][Full Text] [Related]
13. Cross-cascade activation of ERKs and ternary complex factors by Rho family proteins.
Frost JA; Steen H; Shapiro P; Lewis T; Ahn N; Shaw PE; Cobb MH
EMBO J; 1997 Nov; 16(21):6426-38. PubMed ID: 9351825
[TBL] [Abstract][Full Text] [Related]
14. Stimulation of membrane ruffling and MAP kinase activation by distinct effectors of RAS.
Joneson T; White MA; Wigler MH; Bar-Sagi D
Science; 1996 Feb; 271(5250):810-2. PubMed ID: 8628998
[TBL] [Abstract][Full Text] [Related]
15. Synergistic activation of c-fos promoter activity by Raf and Ral GDP dissociation stimulator.
Okazaki M; Kishida S; Hinoi T; Hasegawa T; Tamada M; Kataoka T; Kikuchi A
Oncogene; 1997 Feb; 14(5):515-21. PubMed ID: 9053849
[TBL] [Abstract][Full Text] [Related]
16. Different effects of various phospholipids on Ki-Ras-, Ha-Ras-, and Rap1B-induced B-Raf activation.
Kuroda S; Ohtsuka T; Yamamori B; Fukui K; Shimizu K; Takai Y
J Biol Chem; 1996 Jun; 271(25):14680-3. PubMed ID: 8663012
[TBL] [Abstract][Full Text] [Related]
17. Differential interaction of the ras family GTP-binding proteins H-Ras, Rap1A, and R-Ras with the putative effector molecules Raf kinase and Ral-guanine nucleotide exchange factor.
Herrmann C; Horn G; Spaargaren M; Wittinghofer A
J Biol Chem; 1996 Mar; 271(12):6794-800. PubMed ID: 8636102
[TBL] [Abstract][Full Text] [Related]
18. Normal and oncogenic p21ras proteins bind to the amino-terminal regulatory domain of c-Raf-1.
Zhang XF; Settleman J; Kyriakis JM; Takeuchi-Suzuki E; Elledge SJ; Marshall MS; Bruder JT; Rapp UR; Avruch J
Nature; 1993 Jul; 364(6435):308-13. PubMed ID: 8332187
[TBL] [Abstract][Full Text] [Related]
19. Activated Ras interacts with the Ral guanine nucleotide dissociation stimulator.
Hofer F; Fields S; Schneider C; Martin GS
Proc Natl Acad Sci U S A; 1994 Nov; 91(23):11089-93. PubMed ID: 7972015
[TBL] [Abstract][Full Text] [Related]
20. Identification of the guanine nucleotide dissociation stimulator for Ral as a putative effector molecule of R-ras, H-ras, K-ras, and Rap.
Spaargaren M; Bischoff JR
Proc Natl Acad Sci U S A; 1994 Dec; 91(26):12609-13. PubMed ID: 7809086
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
